ARCHIVES

Phase II Study Tests Chemo Plus Mylotarg For AML

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

Also David Schwartz of Duke University to head NIEHS.

October 29, 2004

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Six Panels To Help NCI Identify Progress; NCINews Roundup

January 8, 1993

CCI Will Tackle Reimbursement Issue

May 16, 1980